Nurse Practitioner, Family · Prince Frederick, MD
NPI
1093209645
Since 2018
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
985 Prince Frederick Blvd, Suite 201
Prince Frederick, MD, 20678
Phone (410) 535-2005
Groups this clinician bills Medicare through
Medicare paid, 2024
$51K
1,683 services
Medicare patients, 2024
402
Average age 76
Drug cost, 2024
$393K
5,146 prescriptions
Company payments, 2025
$406
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Makenzie R Griffin was code 99214 (office e&m - established), 428 times for 290 patients. In total Makenzie R Griffin billed 1,683 services in 59 codes, and Medicare paid $51K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-11-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 428 | 290 | $75.70 | $32K |
| 36415 Venipuncture Blood Collection | Office | 137 | 121 | $8.65 | $1,185 |
| 85025 Blood Count | Office | 76 | 72 | $7.51 | $571 |
| 80053 Clinical Chemistry | Office | 75 | 72 | $10.35 | $776 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 73 | 62 | $9.83 | $718 |
| 81003 Clinical Chemistry | Office | 73 | 58 | $2.20 | $161 |
| 99213 Office E&M - Established | Office | 71 | 63 | $43.53 | $3,090 |
| 80061 Clinical Chemistry | Office | 56 | 54 | $13.12 | $735 |
| 84443 Clinical Chemistry | Office | 50 | 48 | $16.46 | $823 |
| 84439 Clinical Chemistry | Office | 49 | 47 | $8.84 | $433 |
| 83036 Blood Count | Office | 28 | 25 | $9.52 | $267 |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 25 | 24 | $133.26 | $3,332 |
| 82306 Clinical Chemistry | Office | 18 | 17 | $29.01 | $522 |
| 82607 Clinical Chemistry | Office | 18 | 18 | $14.78 | $266 |
| 82746 Clinical Chemistry | Office | 18 | 18 | $14.41 | $259 |
By year: 2022 $14K for 589 services; 2023 $35K for 775 services; 2024 $51K for 1,683 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 137 | 121 | $8.65 | $1,185 |
| 85025 Blood Count | 76 | 72 | $7.51 | $571 |
| 80053 Clinical Chemistry | 75 | 72 | $10.35 | $776 |
| 81003 Clinical Chemistry | 73 | 58 | $2.20 | $161 |
| 80061 Clinical Chemistry | 56 | 54 | $13.12 | $735 |
| 84443 Clinical Chemistry | 50 | 48 | $16.46 | $823 |
| 84439 Clinical Chemistry | 49 | 47 | $8.84 | $433 |
| 83036 Blood Count | 28 | 25 | $9.52 | $267 |
| 82607 Clinical Chemistry | 18 | 18 | $14.78 | $266 |
| 82746 Clinical Chemistry | 18 | 18 | $14.41 | $259 |
Medicare prescription drug claims, 2024
In 2024, the drug Makenzie R Griffin prescribed most often to Medicare patients was Amlodipine Besylate, with 174 prescriptions and refills. In total Makenzie R Griffin wrote 5,146 Medicare prescriptions that cost $393K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 174 | 498 | 68 | $1,375 |
| Alprazolam Generic | 163 | 193 | 43 | $1,030 |
| Atorvastatin Calcium Generic | 159 | 449 | 60 | $1,404 |
| Lisinopril Generic | 157 | 442 | 56 | $1,529 |
| Gabapentin Generic | 138 | 244 | 46 | $2,376 |
| Omeprazole Generic | 137 | 377 | 52 | $2,302 |
| Losartan Potassium Generic | 134 | 378 | 47 | $1,303 |
| Zolpidem Tartrate Generic | 129 | 225 | 36 | $1,521 |
| Levothyroxine Sodium Generic | 125 | 351 | 44 | $989 |
| Prednisone Generic | 121 | 141 | 87 | $357 |
| Pantoprazole Sodium Generic | 116 | 335 | 46 | $1,772 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 107 | 133 | 35 | $2,505 |
| Rosuvastatin Calcium Generic | 99 | 297 | 41 | $1,517 |
| Tramadol Hcl Generic | 98 | 98 | 29 | $1,170 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 91 | 91 | 78 | $767 |
Brand drugs: 507 claims; generic drugs: 4,628 claims; opioid claims: 132.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Makenzie R Griffin $406 ($406 in general payments such as food, travel and fees) from 15 companies. The largest payer was Abbvie Inc. with $52.42.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 3 | $52.42 |
| Novo Nordisk Inc NVO | 3 | $49.03 |
| Astellas Pharma US Inc 4503.T | 2 | $46.74 |
| Aimmune Therapeutics, Inc. | 2 | $34.52 |
| Lilly USA, LLC LLY | 2 | $34.37 |
| Xeris Pharmaceuticals, Inc. | 1 | $23.72 |
| Abbott Laboratories ABT | 1 | $22.31 |
| Daiichi Sankyo Inc. 4568.T | 1 | $21.58 |
| GlaxoSmithKline, LLC. GSK | 1 | $19.94 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $18.91 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.